Bank of India Midcap Tax Fund Sr 2
The scheme seeks to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related securities of midcap companies along with income tax benefit.
Growthvine rating: 4/5 — ranked #14 of 57 in category.
Fund basics
| Category | Equity: ELSS |
|---|
| NAV | ₹34.99 (as of 2026-08-21) |
|---|
| AUM | ₹0 Cr |
|---|
| Expense ratio | 0.00% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Nilesh Jethani |
|---|
| Exit load | 0 |
|---|
Performance & risk
| 5-year annualised return | 11.35% |
|---|
| Sharpe ratio | 0.54 |
|---|
| Standard deviation | 18.52% |
|---|
| Max drawdown | -34.23% |
|---|
| Alpha | 2.42 |
|---|
| Beta | 1.14 |
|---|
Over 5 years, captured 105.9% of Nifty 500's upside and 109.8% of its downside.
Market cap allocation
| Large cap | 9.3% |
|---|
| Mid cap | 70.5% |
|---|
| Small cap | 20.1% |
|---|
Concentration
| Top 5 holdings | 22.8% |
|---|
| Top 10 holdings | 39.2% |
|---|
| Total holdings | 51 |
|---|
| Index overlap | 12.4% |
|---|
| Active share | 87.6% |
|---|
Top holdings
- Lloyds Metals and Energy Limited — 5.7%
- COFORGE LIMITED — 4.8%
- UNO Minda Limited — 4.5%
- Bank of maharashtra — 4.2%
- Steel Authority of India Ltd. — 3.6%
- Federal Bank Ltd. — 3.5%
- Aurobindo Pharma Ltd. — 3.4%
- HDFC Bank Ltd. — 3.3%
- PB Fintech Limited — 3.2%
- Xpro India Ltd. — 3.0%
Top sectors
- Banking & Financial — 15.6%
- Pharma & Biotech — 11.6%
- Industrial Products — 9.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 7.2% | Q1 (Top) | #10 of 52 |
| 2025 | 2.1% | Q3 | #31 of 51 |
| 2024 | 18.5% | Q2 | #26 of 51 |
| 2023 | 35.0% | Q1 (Top) | #11 of 48 |
| 2022 | -6.2% | Q4 (Bottom) | #40 of 43 |